Lv1
70 积分 2021-09-13 加入
Minimal residual disease guided treatment approaches in non-Hodgkin lymphoma—Where we are and where we’re headed
11天前
已完结
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
1个月前
已完结
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
1个月前
已完结
Serial circulating tumor DNA identification associated with the efficacy and prognosis of neoadjuvant chemotherapy in breast cancer
2个月前
已完结
Use of ctDNA in Older Women with ER+ Breast Cancer to Facilitate Surgical De-escalation: A Prospective, Hybrid-Decentralized Trial with Correlative Studies
3个月前
已完结
The clinical application value of dynamic monitoring of HPV ctDNA in concurrent chemoradiotherapy for locally advanced cervical cancer
3个月前
已完结
Circulating DNA changes are predictive of disease progression after transarterial chemoembolization
3个月前
已完结
Circulating tumour DNA for a minimal residual disease assessment and recurrence risk in hepatocellular carcinoma: a systematic review and meta-analysis
3个月前
已完结
Adjuvant sintilimab in resected high-risk hepatocellular carcinoma: a randomized, controlled, phase 2 trial
3个月前
已完结
Cell‐Free Virus‐Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer
3个月前
已完结
皖公网安备34019202002308
